UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MEDICINES CO ownership

MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 45 filers reported holding MEDICINES CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of MEDICINES CO
ValueSharesWeighting
Q4 2017$28,345,762,000
-46.3%
26,785,000
-35.9%
0.02%
-50.0%
Q3 2017$52,816,658,000
+5.3%
41,785,000
+9.1%
0.05%
-2.0%
Q2 2017$50,168,664,000
+14.4%
38,285,000
+37.8%
0.05%
+8.9%
Q1 2017$43,854,177,000
+109368.5%
27,785,000
-17.0%
0.04%0.0%
Q4 2016$40,061,000
-0.6%
33,485,000
+8.1%
0.04%
+4.7%
Q3 2016$40,319,000
+5.6%
30,985,000
-3.7%
0.04%0.0%
Q2 2016$38,169,00032,165,0000.04%
Other shareholders
MEDICINES CO shareholders Q1 2018
NameSharesValueWeighting ↓
City Financial Investment Co Ltd 30,000,000$25,879,0004.60%
Cheyne Capital Management (UK) LLP 4,000,000$3,447,0003.26%
DeepCurrents Investment Group LLC 27,250,000$23,546,0002.93%
Worth Venture Partners, LLC 4,078,000$3,482,0002.63%
SILVERBACK ASSET MANAGEMENT LLC 11,000,000$9,515,0001.76%
DLD Asset Management, LP 27,500,000$23,994,0001.64%
Myriad Asset Management Ltd. 7,000,000$6,112,0001.30%
Context Capital Management, LLC 2,000,000$1,726,0000.98%
Verition Fund Management LLC 13,347,000$11,518,0000.83%
Castle Creek Arbitrage, LLC 2,157,000$1,860,0000.64%
View complete list of MEDICINES CO shareholders